<DOC>
	<DOCNO>NCT00697086</DOCNO>
	<brief_summary>The purpose study assess efficacy dronedarone control ventricular rate rest exercise patient atrial fibrillation ( AF ) ass tolerability dronedarone target population .</brief_summary>
	<brief_title>European Study Dronedarone Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<criteria>Patients symptomatic permanent AF ( &gt; 6 month ) cardioversion consider rest ventricular rate &gt; equal 80 bpm screening measure 6seconds rhythm strip , Unstable angina pectoris , recent myocardial infarction history torsades de pointes Third degree atrioventricular block screen ECG significant sinus node disease without permanent pacemaker implant Clinically overt congestive heart failure randomization Patients treat amiodarone , antiarrhythmic drug previous participation trial dronedarone trial take investigational drug Clinically relevant haematologic , hepatic , gastrointestinal , renal , pulmonary , endocrinologic psychiatric disease Pregnant and/or breastfeed woman woman childbearing potential adequate birth control The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Heart disease</keyword>
</DOC>